Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

August 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Olanzapine

DRUG

Aripiprazole

Trial Locations (5)

38117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test, Memphis

44122

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test, Beachwood

44708

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test, Canton

63301

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test, Saint Charles

00926

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. test, Rio Piedras

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00103571 - Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With Schizophrenia | Biotech Hunter | Biotech Hunter